Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
Last trade$1.93
Day change+$0.005 (+0.26%)
Day range$1.87 – $2.23
Volume10,750,984
Market cap$287M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$287.65M
Price / earnings
—
Price / book
2.06×
Price / sales
—
EV / sales
—
EV / EBITDA
-15.75×
Profitability
Earnings per share
-$0.01
Return on assets
-0.61%
Return on equity
-0.63%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
79.19×
Quick ratio
79.19×
Cash ratio
4.39×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$21.06M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for CYPH, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Revenue
$0
$0
$0
Cost of revenue
$0
$0
$0
Gross profit
$0
$0
$0
Selling, general and administrative
$4.49M
$4.66M
$4.13M
Research and development
$197K
$161K
$975K
Total operating expenses
$4.69M
$4.82M
$5.1M
Operating income
-$4.69M
-$4.82M
-$5.1M
Interest expense
-$6K
-$7K
-$1K
Income before taxes
$41.36M
-$82.28M
$45.26M
Income taxes
$1.97M
-$5.12M
$5.05M
Net income
$39.39M
-$77.17M
$40.2M
Net income attributable to common shareholders
$39.39M
-$77.17M
$40.2M
EBITDA
-$4.69M
-$4.82M
-$5.1M
Basic earnings per share
$0.21
-$0.46
$0.29
Diluted earnings per share
$0.18
-$0.46
$0.25
Recent news
Company coverage with links to the original publishers.
Zcash and Hyperliquid are positioned for potential 100% gains by 2029-2030, with backing from prominent investors. Zcash, a privacy-focused coin similar to Bitcoin, has support from Winklevoss Capital and Naval Ravikant. Hyperliquid, a decentralized exchange for perpetual futures, benefits from 99% of protocol fees funding token buybacks and institutional interest from Cantor Fitzgerald and Stanley Druckenmiller's Duquesne Family Office.
The article argues that AI and semiconductor stocks are trading at expensive valuations with uncertain growth prospects. Instead, the author recommends Zcash and Solana as better investment alternatives. Zcash benefits from regulatory acceptance through selective disclosure features and institutional adoption via ETFs, while Solana is positioned to grow through tokenized assets and AI agents on its network.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.